close
  • home Home

  • linked_services Solutions keyboard_arrow_down

  • experiment Services keyboard_arrow_down

  • support Support & Resources keyboard_arrow_down

  • apartment Company keyboard_arrow_down

  • mail Contact

  • Solutions
    keyboard_arrow_down
  • Services
    keyboard_arrow_down
  • Support & Resources
    keyboard_arrow_down
  • Company
    keyboard_arrow_down
  • Contact
Randox Health search menu

Vivalytic | SARS-CoV-2 Dual Target, Influenza A/B and RSV

Rapid differentiation between SARS-CoV-2, Flu A/B, and RSV

SARS-CoV-2 Dual Target, Influenza A/B and RSV Rapid Test

detector

Detection from real-time PCR via Nasopharyngeal and/or Oropharyngeal swab

check_circle

The SARS-CoV-2 DT, Flu A/B and RSV rapid test has recently received CE marking

acute

Rapid turnaround time of 53 minutes from sample entry to result

coronavirus

Targets the E gene and N gene sequences for COVID-19 detection, as well as Influenza A and Influenza B and human Respiratory Syncytial Virus

barefoot

Simple and easy to use analyser with a small footprint making it suitable for use in laboratory and non-laboratory settings

counter_4

Convenient 4 step process from sample entry to results. No laboratory training required

Clinical Significance

Patients afflicted with SARS-CoV-2, Influenza A (Flu A), Influenza B (Flu B), and/or Respiratory Syncytial Virus (RSV) often exhibit similar symptoms, yet necessitate distinct approaches to management. The SARS-CoV-2, Flu A/B, and RSV qualitative test streamlines the rapid triage and patient management process, swiftly identifying various viruses in under 1 hour.

This panel enables healthcare professionals to administer pathogen-specific treatments and targeted interventions effectively. By combining these tests, healthcare facilities not only streamline costs but also address the complexities of respiratory infections directly at the point of care. This integrated approach facilitates infection control measures and enhances risk assessment, ultimately contributing to more efficient and tailored patient care.

Features

Sample TypeNasopharyngeal or Oropharyngeal Swab (eNAT)
Sample Volume 300 μl
Detection MethodReal-Time PCR
Time to result53 minutes
Detectable Pathogens
SARS-CoV-2 (E gene & N gene)
Influenza A and Influenza B
Human Respiratory Syncytial Virus

"AWARD-WINNING DESIGN DELIVERS AN UNCOMPLICATED USER EXPERIENCE"

Vivalytic Workflow

Intuitive engineering of Vivalytic ensures the analyser is user friendly. The process of patient sample to result comprises a very simple 4 step workflow.

To begin the test, the user scans or enters sample information. The cartridge code is then scanned into the embedded Vivalytic software. The user then adds sample into the dedicated cartridge slot, closes the lid and inserts the cartridge into the Vivalytic.

The touchscreen display will countdown the time remaining to test completion. Results will be displayed on the screen. Multiple Vivalytics can be wirelessly connected allowing the user to control multiple tests at one time all reporting to a master Vivalytic platform.

Get in touch to discover more

To find out more about the Vivalytic or to discuss arranging a demo, enquire now.